PNC Financial Services Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $189K | Hold |
11,623
| – | – | ﹤0.01% | 2432 |
|
|
2026
Q2 | $209K | Hold |
11,623
| – | – | ﹤0.01% | 2325 |
|
|
2026
Q1 | $109K | Sell |
11,623
-912
| -7% | -$10K | ﹤0.01% | 2655 |
|
|
2025
Q4 | $156K | Hold |
12,535
| – | – | ﹤0.01% | 2384 |
|
|
2025
Q3 | $180K | Buy |
12,535
+67
| +0.5% | +$918 | ﹤0.01% | 2274 |
|
|
2025
Q2 | $153K | Sell |
12,468
-3,400
| -21% | -$49.4K | ﹤0.01% | 2288 |
|
|
2025
Q1 | $349K | Buy |
15,868
+320
| +2% | +$7.52K | ﹤0.01% | 1661 |
|
|
2024
Q4 | $353K | Buy |
15,548
+3,746
| +32% | +$81.8K | ﹤0.01% | 1659 |
|
|
2024
Q3 | $214K | Sell |
11,802
-5,516
| -32% | -$128K | ﹤0.01% | 2029 |
|
|
2024
Q2 | $505K | Buy |
17,318
+4,365
| +34% | +$129K | ﹤0.01% | 1385 |
|
|
2024
Q1 | $459K | Sell |
12,953
-154
| -1% | -$6.16K | ﹤0.01% | 1474 |
|
|
2023
Q4 | $571K | Sell |
13,107
-127
| -1% | -$5K | ﹤0.01% | 1326 |
|
|
2023
Q3 | $505K | Sell |
13,234
-7,193
| -35% | -$303K | ﹤0.01% | 1364 |
|
|
2023
Q2 | $840K | Sell |
20,427
-1,739
| -8% | -$83.7K | ﹤0.01% | 1137 |
|
|
2023
Q1 | $1.27M | Buy |
22,166
+265
| +1% | +$14.9K | ﹤0.01% | 962 |
|
|
2022
Q4 | $1.23M | Sell |
21,901
-1,694
| -7% | -$86.2K | ﹤0.01% | 971 |
|
|
2022
Q3 | $999K | Buy |
23,595
+1,100
| +5% | +$56.4K | ﹤0.01% | 1045 |
|
|
2022
Q2 | $1.22M | Sell |
22,495
-352
| -2% | -$21.1K | ﹤0.01% | 1002 |
|
|
2022
Q1 | $1.47M | Sell |
22,847
-3,912
| -15% | -$258K | ﹤0.01% | 981 |
|
|
2021
Q4 | $1.79M | Buy |
26,759
+506
| +2% | +$34.2K | ﹤0.01% | 944 |
|
|
2021
Q3 | $1.8M | Buy |
26,253
+594
| +2% | +$42K | ﹤0.01% | 881 |
|
|
2021
Q2 | $1.75M | Buy |
25,659
+369
| +1% | +$26.1K | ﹤0.01% | 896 |
|
|
2021
Q1 | $1.75M | Buy |
25,290
+1,092
| +5% | +$74K | ﹤0.01% | 862 |
|
|
2020
Q4 | $1.57M | Sell |
24,198
-263
| -1% | -$14.2K | ﹤0.01% | 867 |
|
|
2020
Q3 | $1.16M | Sell |
24,461
-4,280
| -15% | -$204K | ﹤0.01% | 905 |
|
|
2020
Q2 | $1.35M | Buy |
28,741
+2,383
| +9% | +$117K | ﹤0.01% | 844 |
|
|
2020
Q1 | $1.18M | Buy |
26,358
+1,500
| +6% | +$78.7K | ﹤0.01% | 823 |
|
|
2019
Q4 | $1.45M | Sell |
24,858
-21,754
| -47% | -$1.29M | ﹤0.01% | 842 |
|
|
2019
Q3 | $2.8M | Sell |
46,612
-10,506
| -18% | -$626K | ﹤0.01% | 785 |
|
|
2019
Q2 | $3.19M | Buy |
57,118
+4,213
| +8% | +$217K | ﹤0.01% | 790 |
|
|
2019
Q1 | $2.95M | Sell |
52,905
-1,006
| -2% | -$51.2K | ﹤0.01% | 834 |
|
|
2018
Q4 | $2.43M | Sell |
53,911
-1,255
| -2% | -$68.9K | ﹤0.01% | 870 |
|
|
2018
Q3 | $3.63M | Buy |
55,166
+1,724
| +3% | +$107K | ﹤0.01% | 805 |
|
|
2018
Q2 | $3.44M | Sell |
53,442
-765
| -1% | -$47.4K | ﹤0.01% | 807 |
|
|
2018
Q1 | $3M | Sell |
54,207
-2,991
| -5% | -$157K | ﹤0.01% | 830 |
|
|
2017
Q4 | $2.74M | Buy |
57,198
+306
| +0.5% | +$15K | ﹤0.01% | 875 |
|
|
2017
Q3 | $2.87M | Buy |
56,892
+37,094
| +187% | +$1.91M | ﹤0.01% | 842 |
|
|
2017
Q2 | $1.08M | Sell |
19,798
-565
| -3% | -$27K | ﹤0.01% | 1143 |
|
|
2017
Q1 | $858K | Buy |
20,363
+373
| +2% | +$15.9K | ﹤0.01% | 1242 |
|
|
2016
Q4 | $858K | Sell |
19,990
-3,098
| -13% | -$126K | ﹤0.01% | 1245 |
|
|
2016
Q3 | $952K | Sell |
23,088
-1,184
| -5% | -$49.6K | ﹤0.01% | 1173 |
|
|
2016
Q2 | $969K | Sell |
24,272
-800
| -3% | -$28.8K | ﹤0.01% | 1157 |
|
|
2016
Q1 | $844K | Buy |
25,072
+5,842
| +30% | +$182K | ﹤0.01% | 1224 |
|
|
2015
Q4 | $652K | Sell |
19,230
-6,372
| -25% | -$199K | ﹤0.01% | 1259 |
|
|
2015
Q3 | $762K | Buy |
25,602
+4,338
| +20% | +$136K | ﹤0.01% | 1238 |
|
|
2015
Q2 | $716K | Buy |
21,264
+1,156
| +6% | +$37.7K | ﹤0.01% | 1316 |
|
|
2015
Q1 | $619K | Buy |
20,108
+494
| +3% | +$14.3K | ﹤0.01% | 1338 |
|
|
2014
Q4 | $532K | Buy |
19,614
+3,064
| +19% | +$76K | ﹤0.01% | 1362 |
|
|
2014
Q3 | $411K | Sell |
16,550
-2,800
| -14% | -$68.2K | ﹤0.01% | 1419 |
|
|
2014
Q2 | $456K | Hold |
19,350
| – | – | ﹤0.01% | 1321 |
|
|
2014
Q1 | $445K | Buy |
19,350
+150
| +0.8% | +$3.54K | ﹤0.01% | 1302 |
|
|
2013
Q4 | $458K | Sell |
19,200
-2,056
| -10% | -$46.1K | ﹤0.01% | 1268 |
|
|
2013
Q3 | $428K | Buy |
21,256
+56
| +0.3% | +$1.1K | ﹤0.01% | 1286 |
|
|
2013
Q2 | $388K | Hold |
21,200
| – | – | ﹤0.01% | 1270 |
|
Other funds holding IART
PNC Financial Services Group's IART Position: Q3 2026 in Review
PNC Financial Services Group held its Integra LifeSciences (IART) position steady in Q3 2026 at 11,623 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.
PNC Financial Services Group first reported a position in IART in Q2 2013 and has held it in 54 quarters since. The position peaked at $3.63M in Q3 2018. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- PNC Financial Services Group held 11,623 shares of Integra LifeSciences worth $189K as of Q3 2026.
- PNC Financial Services Group left its Integra LifeSciences share count unchanged in Q3 2026.
- Integra LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2432 holding.
- PNC Financial Services Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 54 quarters since.
- PNC Financial Services Group's Integra LifeSciences position peaked at $3.63M in Q3 2018.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.